EcoR1 Capital LLC 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:18 pm Purchase | 2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | EcoR1 Capital LLC | 11,173,068 9.400% | 4,865,521 (+77.14%) | Filing |
| 2023-07-18 5:16 pm Purchase | 2023-07-18 | 13G | Apellis Pharmaceuticals, Inc. APLS | EcoR1 Capital LLC | 6,307,547 5.400% | 6,307,547 (New Position) | Filing |